The latest update is out from Repligen (RGEN).
Repligen Corporation has announced a significant leadership change with Tony J. Hunt stepping down as CEO to become the Executive Chair. Olivier Loeillot, currently President and Chief Commercial Officer, will take over as CEO starting September 1, 2024. Additionally, Karen A. Dawes will transition from her position as the Chair of the board to Lead Independent Director on the same date. This strategic shift in roles marks a new chapter for Repligen as it continues to navigate the evolving financial markets.
For detailed information about RGEN stock, go to TipRanks’ Stock Analysis page.
